GEN - Genetic Engineering & Biotech NewsOriginal article
Chimeric Allergen Receptor Treg Cells Suppress Allergic Asthma in Mice
Phase 1positiveCAlleR TregsPositive
AI Analysis
Summary
Researchers developed chimeric allergen receptor regulatory T cells (CAlleR Tregs) that suppressed allergic asthma symptoms in mice sensitized to birch pollen allergen, demonstrating potential for treating various allergies in humans.
Clinical Trial Data
Phase
preclinical
Primary Endpoint
Met
Outcome Details
Reduced or prevented asthma symptoms in mice sensitized to birch tree pollen allergen
Importance:3/10
Sentiment:
0.60
cell therapyregulatory T cellsallergyasthmapreclinicalimmunotherapy
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on July 6, 2026 4:13 PM